AstraZeneca Plc - Company Profile

Powered by

All the data and insights you need on AstraZeneca Plc in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date AstraZeneca Plc Strategy Report

  • Understand AstraZeneca Plc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

AstraZeneca Plc: Overview

Select Item

Related keylists

View more

AstraZeneca Plc (AstraZeneca) is a biopharmaceutical company, which is focused on discovery, production and commercialization of a range of prescription drugs. It develops products related to therapy areas such as respiratory, cardiovascular, renal and metabolic diseases, cancer, autoimmune, infection and neurological diseases. The company’s product portfolio includes biologics, prescription pharmaceuticals and vaccines. AstraZeneca sells its products through wholly- owned local marketing companies, distributors and local representative offices. The company markets its products to primary care and specialty care physicians. The company operates in Europe, the Americas, Asia, Africa and Australasia. AstraZeneca is headquartered in Cambridge, Cambridgeshire, the UK.

 Gain a 360-degree view of AstraZeneca Plc and make more informed decisions for your business Gain a 360-degree view of AstraZeneca Plc and make more informed decisions for your business Find out more
Headquarters United Kingdom
Address 1 Francis Crick Avenue, Cambridge Biomedical Campus, England, CB20AA
Website www.astrazeneca.com
Telephone 44 20 37495000
No of Employees 83,500
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange AZN (LON)
Revenue (2022) $44.4B 18.5% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ 2835.7% (2022 vs 2021)
Market Cap* $196.8B
Net Profit Margin (2022) XYZ 2,370.0% (2022 vs 2021)
* As of and is in US$
View AstraZeneca Plc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

AstraZeneca Plc premium industry data and analytics

5,600+

Clinical Trials

Determine AstraZeneca Plc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

3,100+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for AstraZeneca Plc’s relevant decision makers and contact details.

2,900+

Catalyst Calendar

Proactively evaluate AstraZeneca Plc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

910+

Pipeline Drugs

Identify which of AstraZeneca Plc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

780+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

260+

Marketed Drugs

Understand AstraZeneca Plc’s commercialized product portfolio to stay one step ahead of the market.

150+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

110+

Sales & Consensus Forecasts

Understand the current and future drug revenue for AstraZeneca Plc and assess market opportunity for new entrants with patient population 8-year forecasts.

3

Investigators

Review investigator profiles and find information on trial contacts across AstraZeneca Plc, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

30+

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for AstraZeneca Plc (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on AstraZeneca Plc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Oncology: -
Calquence: Acalabrutinib Accolate
Enhertu: Trastuzumab Deruxtecan Arimidex
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand AstraZeneca Plc portfolio and identify potential areas for collaboration Understand AstraZeneca Plc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In December, the company entered into a partnership with Absci Corp to advance an AI-designed antibody against an oncology target.
2023 New Products/Services In November, the company launched Evinova.
2023 Financing Agreements In November, the company signed a memorandum of understanding to invest US$140 million in Cellectis.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters AstraZeneca Plc Pfizer Inc Johnson & Johnson F. Hoffmann-La Roche Ltd Merck & Co Inc
Headquarters United Kingdom United States of America United States of America Switzerland United States of America
City Cambridge New York New Brunswick Basel Kenilworth
State/Province England New York New Jersey - New Jersey
No. of Employees 83,500 83,000 152,700 103,613 69,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Pascal Soriot Director; Chief Executive Officer Executive Board 2012 -
Aradhana Sarin Chief Financial Officer; Director Executive Board 2021 -
Marc Dunoyer Chief Strategy Officer; Chief Executive Officer - Alexion Senior Management 2021 -
Pam P. Cheng Executive Vice President - Operations and Information Technology; Chief Sustainability Officer Senior Management 2023 -
Jeff Pott Chief Compliance Officer; General Counsel; Chief Human Resources Officer Senior Management 2023 -
Non Dignissim Eros Proin vel Convallis 2023 XY
Non Dignissim Eros Proin vel Convallis 2023 XY
Non Dignissim Eros Proin vel Convallis 2023 XY
Gain insight into AstraZeneca Plc key executives to enhance your sales strategy Gain insight into AstraZeneca Plc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward